Processa Pharmaceuticals (PCSA) Q3 2024 Earnings

28AugConfirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
-1.18
-0.81
-0.45
-0.08

Details

Expected EPS
-1.01
Actual EPS
-1.01
Surprise EPS
0
Surprise Percent
+0%

Description

Processa Pharmaceuticals (PCSA) has reported earnings of -1.01 per share for Q3 2024.

0 Comments

Share your thoughts